Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients Ami AokiChiaki IwamuraKiyoshi Hirahara Original Article Open access 22 April 2024 Article: 104
Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Takako SuzukiYoshitaka SatoJun-ichi Kawada Research 20 April 2024 Article: 103
Phenotypic and Immunological Characterization of Patients with Activated PI3Kδ Syndrome 1 Presenting with Autoimmunity Qifan LiWenjie WangJinqiao Sun Research Open access 18 April 2024 Article: 102
Inborn Errors of Immunity in Jordan: First Report from a Tertiary Referral Center Raed AlzyoudMotasem AlsuweitiHamazh Nsour Research 17 April 2024 Article: 101
Severe Herpes Simplex Encephalitis: an Unusual Presentation of IPEX Linda RossiniClaudia Maria BonardiAntonio Marzollo Letter to Editor 16 April 2024 Article: 100
Mendelian Causes of Autoimmunity: the Lupus Phenotype Maud TusseauSamira Khaldi-PlassartAlexandre Belot Review 15 April 2024 Article: 99
Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3 Christo TsilifisJarmila Stremenova SpegarovaAndrew R. Gennery Research Open access 10 April 2024 Article: 98
Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine Lorne SchweitzerSapha BarkatiDonald C. Vinh Letter to Editor 08 April 2024 Article: 97
Novel Synonymous Variant in IL7R Causes Preferential Expression of the Soluble Isoform Rafah MackehYasmin El BsatBernice Lo Original Article Open access 08 April 2024 Article: 96
OTULIN Haploinsufficiency Causes Hyperinflammatory Responses to Infectious and Non-Infectious Triggers Laura Batlle-MasóMaria AntolinRoger Colobran Correspondence 05 April 2024 Article: 95
Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion Ibrahim Serhat KarakusMehmet Cihangir CatakSafa Baris Original Article Open access 05 April 2024 Article: 94
Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns Andrey V. MarakhonovIrina Yu. EfimovaSergey I. Kutsev Research 05 April 2024 Article: 93
Analysis of Clinical, Immunological and Molecular Features of Leukocyte Adhesion Deficiency Type I in Egyptian Children Mai Magdy SaadRadwa AlkadyAisha M. Elmarsafy Research Open access 05 April 2024 Article: 92
Monozygotic Twins with MAGT1 Deficiency and Epstein–Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report Jiachen WangMi ZhouLiang Huang Letter to Editor Open access 05 April 2024 Article: 91
An Indian Family with Autosomal Dominant Hyper-IgE Syndrome Due to IL6ST Defect Suprit BasuShubham GoelBiman Saikia Letter to Editor 05 April 2024 Article: 90
A deep intronic BTK variant underlies X-linked agammaglobulinemia Shoichiro TateishiShoichi ShimizuKohsuke Imai Correspondence 05 April 2024 Article: 89
Proteasome-Associated Syndromes: Updates on Genetics, Clinical Manifestations, Pathogenesis, and Treatment Jiahui ZhangPanfeng TaoQing Zhou Review 05 April 2024 Article: 88
22q11.2 Deletion-Associated Blood-Brain Barrier Permeability Potentiates Systemic Capillary Leak Syndrome Neurologic Features Alexis M. CrockettHania KebirJorge I. Alvarez Research 05 April 2024 Article: 87
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report John McDonnellKimberley CousinsRebecca Marsh Original Article Open access 05 April 2024 Article: 86
Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib Laura DottaFrancesca TodaroRaffaele Badolato Research Open access 05 April 2024 Article: 85
Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF June-Young KohDoo Ri KimEui-Cheol Shin Original Article Open access 05 April 2024 Article: 84